Cargando…

Treatment strategies for unruptured pancreaticoduodenal artery aneurysms associated with celiac artery occlusion

Celiac artery (CA) occlusion or stenosis is identified in up to almost half of all patients undergoing abdominal angiography, and the resulting increased collateral blood flow from the superior mesenteric artery to the pancreaticoduodenal artery (PDA) may cause PDA aneurysms (PDAAs). PDAAs are rare...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Koji, Shimizu, Akira, Notake, Tsuyoshi, Wada, Yuko, Soejima, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831908/
https://www.ncbi.nlm.nih.gov/pubmed/36643356
http://dx.doi.org/10.1002/ags3.12609
_version_ 1784867949439352832
author Kubota, Koji
Shimizu, Akira
Notake, Tsuyoshi
Wada, Yuko
Soejima, Yuji
author_facet Kubota, Koji
Shimizu, Akira
Notake, Tsuyoshi
Wada, Yuko
Soejima, Yuji
author_sort Kubota, Koji
collection PubMed
description Celiac artery (CA) occlusion or stenosis is identified in up to almost half of all patients undergoing abdominal angiography, and the resulting increased collateral blood flow from the superior mesenteric artery to the pancreaticoduodenal artery (PDA) may cause PDA aneurysms (PDAAs). PDAAs are rare but could be fatal if they rupture. However, treatment of the PDAA could block this important collateral blood flow pathway, leading to ischemic organ damage. Treatment of such aneurysms is therefore difficult, especially in patients with multiple PDAAs. Successful treatment of PDAAs requires establishing blood flow in the CA region and selecting which aneurysm(s) to treat. We present four patients who underwent surgery for unruptured PDAAs caused by CA obstruction. Blood flow in the CA region was established by bypassing the splenic artery and by anastomosing it either directly to the left renal artery (n = 1) or to the abdominal aorta using a graft (saphenous vein: n = 1; artificial vessel: n = 2). Three patients had multiple PDAAs: all PDAAs were treated in one patient with PDAAs of similar size and shape, but only the largest PDAA with the highest risk of rupture was treated in the other two patients to simplify the procedure. The median observation period was 19.5 months (range: 11‐28 months), and all patients were alive without recurrence at the time of writing. Surgical treatment including splenic artery bypass may thus be a viable option for treating patients with unruptured PDAAs.
format Online
Article
Text
id pubmed-9831908
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98319082023-01-12 Treatment strategies for unruptured pancreaticoduodenal artery aneurysms associated with celiac artery occlusion Kubota, Koji Shimizu, Akira Notake, Tsuyoshi Wada, Yuko Soejima, Yuji Ann Gastroenterol Surg How I Do It Celiac artery (CA) occlusion or stenosis is identified in up to almost half of all patients undergoing abdominal angiography, and the resulting increased collateral blood flow from the superior mesenteric artery to the pancreaticoduodenal artery (PDA) may cause PDA aneurysms (PDAAs). PDAAs are rare but could be fatal if they rupture. However, treatment of the PDAA could block this important collateral blood flow pathway, leading to ischemic organ damage. Treatment of such aneurysms is therefore difficult, especially in patients with multiple PDAAs. Successful treatment of PDAAs requires establishing blood flow in the CA region and selecting which aneurysm(s) to treat. We present four patients who underwent surgery for unruptured PDAAs caused by CA obstruction. Blood flow in the CA region was established by bypassing the splenic artery and by anastomosing it either directly to the left renal artery (n = 1) or to the abdominal aorta using a graft (saphenous vein: n = 1; artificial vessel: n = 2). Three patients had multiple PDAAs: all PDAAs were treated in one patient with PDAAs of similar size and shape, but only the largest PDAA with the highest risk of rupture was treated in the other two patients to simplify the procedure. The median observation period was 19.5 months (range: 11‐28 months), and all patients were alive without recurrence at the time of writing. Surgical treatment including splenic artery bypass may thus be a viable option for treating patients with unruptured PDAAs. John Wiley and Sons Inc. 2022-08-02 /pmc/articles/PMC9831908/ /pubmed/36643356 http://dx.doi.org/10.1002/ags3.12609 Text en © 2022 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle How I Do It
Kubota, Koji
Shimizu, Akira
Notake, Tsuyoshi
Wada, Yuko
Soejima, Yuji
Treatment strategies for unruptured pancreaticoduodenal artery aneurysms associated with celiac artery occlusion
title Treatment strategies for unruptured pancreaticoduodenal artery aneurysms associated with celiac artery occlusion
title_full Treatment strategies for unruptured pancreaticoduodenal artery aneurysms associated with celiac artery occlusion
title_fullStr Treatment strategies for unruptured pancreaticoduodenal artery aneurysms associated with celiac artery occlusion
title_full_unstemmed Treatment strategies for unruptured pancreaticoduodenal artery aneurysms associated with celiac artery occlusion
title_short Treatment strategies for unruptured pancreaticoduodenal artery aneurysms associated with celiac artery occlusion
title_sort treatment strategies for unruptured pancreaticoduodenal artery aneurysms associated with celiac artery occlusion
topic How I Do It
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831908/
https://www.ncbi.nlm.nih.gov/pubmed/36643356
http://dx.doi.org/10.1002/ags3.12609
work_keys_str_mv AT kubotakoji treatmentstrategiesforunrupturedpancreaticoduodenalarteryaneurysmsassociatedwithceliacarteryocclusion
AT shimizuakira treatmentstrategiesforunrupturedpancreaticoduodenalarteryaneurysmsassociatedwithceliacarteryocclusion
AT notaketsuyoshi treatmentstrategiesforunrupturedpancreaticoduodenalarteryaneurysmsassociatedwithceliacarteryocclusion
AT wadayuko treatmentstrategiesforunrupturedpancreaticoduodenalarteryaneurysmsassociatedwithceliacarteryocclusion
AT soejimayuji treatmentstrategiesforunrupturedpancreaticoduodenalarteryaneurysmsassociatedwithceliacarteryocclusion